Highlander Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Highlander Capital Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,500	Closed	-$9	–	987
2023 Q4	$9	Hold	3,500	–	–	﹤0.01%	978
2023 Q3	$0	Buy	+3,500	New	+$464	﹤0.01%	949

Highlander Capital Management's INFI Position: Q1 2024 in Review

Highlander Capital Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2024, closing a stake of 3,500 shares — an estimated $9 sold.

Highlander Capital Management first reported a position in INFI in Q3 2023 and held it in 2 quarters. The position peaked at $9 in Q4 2023. 1 fund tracked by Wall St. Rank holds INFI as of Q1 2024.

Highlander Capital Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
Highlander Capital Management sold 3,500 Infinity Pharmaceuticals, Inc. shares in Q1 2024, an estimated $9.
Highlander Capital Management first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2023 and held it in 2 quarters.
Highlander Capital Management's Infinity Pharmaceuticals, Inc. position peaked at $9 in Q4 2023.
1 fund tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2024.

Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.